InvestSMART

Moderna (NASDAQ: MRNA) - Share Price

Current share price for MRNA : $148.860 1.95 (1.29%)+

Currency: USD ($)

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

MRNA General Information +

NASDAQ Code MRNA
Industry/Sector Biotechnology
Market Cap ($M) 59,430
MRNA Share Price $148.860
Day High $150.000
Day Low $142.790
Last Close $150.810
MRNA Share Price Movement $1.95 ( 1.29% )
Prices as at 3:44, 4 Sep 2026
+Security prices are at best end-of-day and are indicative only.

MRNA Financial Summary

Operating Revenue Per Share Price to Operating revenue Price to free cash flow Earnings Yield PE Ratio Dividend Yield Forward Dividend Yield Forward Earnings Yield
$22.77 $6.39 ($46.04) 3.78% 26.46 n/a n/a -2.65

MRNA Calendar of Events

Created Date Changed Date Event
17 March 2026 17 March 2026 Company Meeting

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.